Powder Systems Limited “Powder Systems Limited (PSL) has been exporting its technology to the Asia-Pacific market since 1990 and a growing number of turn-key installations are to be commissioned in this region in the future. To support the demand, PSL has committed to further investment in Asia-Pacific (APAC) by opening an engineering and sales office […]
Condition: Medicated for patients suffering from Obesity. Effectiveness: ★★★ Ease of Use: ★★★★ Satisfactory Index: ★★ Weight-loss drug Belviq also known as lorcaserin HCI has been popular in the market because it’s known to help reducing obesity amongst adults. During the clinical trials, however, side effects like headache, upper respiratory tract infection, nasopharyngitis, sinusitis and […]
Condition: Estrogen Receptor (ER)-Positive, HER2-Negative Postmenopausal Effectiveness: ★★★ Ease of Use: ★★★ Satisfactory Index: ★★★ Therapeautic drug, Ibrance (Chemical name: Palbociclib), recently approved by the U.S. Food and Drug Administration in February 2015, is intended to be paired with the hormonal therapy medicine Femara (Chemical name: Letrozole) as a comprehensive treatment for locally advanced-stage or metastatic, hormone-receptor-positive, HER2-negative […]
The historical approach to clinical drug development, and one that served drug companies well for the past thirty years, was to initiate testing in humans at clinical research units, typically located in the UK and the US and to proceed further to Phase II testing and beyond to patients with clinical evidence of the disease […]
The incidence of Central Nervous System (CNS) illness is on the upswing and exacts a heavy human and economic toll. According to the World Health Organization, more than 120 million people worldwide suffer from depression, and the number is expected to rise. The occurrence of Alzheimer’s disease is slated to grow by more than 100 […]
Over the past decade there has been increasing pressure on the pharmaceutical industry to increase economic efficiencies in drug discovery. This has been driven by several factors including the increased costs of R&D, lower productivity, patent expiration, generic competition and the increasing difficulty in bringing new chemical entities to market. The extraordinary investment requirements have […]
Edward Jenner’s work in developing the world’s first smallpox vaccine in the 1790s demonstrated that it was possible to protect the general population from major threats to public health, and vaccine development aimed at combating the major concerns of the day has continued ever since. There have been many successes, and vaccines are now available […]
Why are some firms more competitive than others? This is the central question of my research in the field of strategic management. Decades of research, in both the life sciences and other industries, have converged to suggest there are perhaps three overarching reasons. The first is the most obvious: what academics call the ‘Resource-Based View […]
Collaborations are the voluntary, joint actions of two or more parties to achieve a common goal. This is a straightforward concept in principle, but often more complex in the real world. Within the pharmaceutical and biotechnology sectors, one can easily identify at least six major classes of stakeholders, viz. private industry, academia, regulatory agencies, governments […]
In an environment where development costs have increased exponentially while filings and launches have dropped drastically, the pharmaceutical industry and drug regulators face numerous challenges in Pharmacovigilance (PV), patient safety and in addressing areas of unmet medical needs. This combination of issues not only adds unsustainable access restrictions and costs in the long term, but […]